首页> 美国政府科技报告 >First Case Report of SAM (registered trademark) Junctional Tourniquet Use in Afghanistan to Control Inguinal Hemorrhage on the Battlefield.
【24h】

First Case Report of SAM (registered trademark) Junctional Tourniquet Use in Afghanistan to Control Inguinal Hemorrhage on the Battlefield.

机译:sam(注册商标)Junctional Tourniquet在阿富汗用于控制战场腹股沟出血的首例病例报告。

获取原文

摘要

Junctional hemorrhage, bleeding that occurs at the junction of the trunk and its appendages, is the most common preventable cause of death from compressible hemorrhage on the battlefield. As of January 2014, four types of junctional tourniquets have been developed and cleared by the U.S. Food and Drug Administration (FDA). Successful use of the Abdominal Aortic Tourniquet (AAT ) and Combat Ready Clamp (CRoC ) has already been reported. We report here the first known prehospital use of the SAM Junctional Tourniquet (SJT) for a battlefield casualty with inguinal junctional hemorrhage.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号